Vladimir Vexler, Chief Scientific Officer at Coherus BioSciences, Inc. (CHRS), sold 134,276 shares at $18.24 ($2.4M) on 2020-12-09, disclosed to the SEC on 2020-12-11.
Open-market sale of $2.4M CHRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.24 | 49,512 | $903K | 37.0% |
| 2 | $18.24 | 49,512 | $903K | 37.0% |
| 3 | $18.05 | 17,626 | $318K | 13.0% |
| 4 | $18.05 | 17,626 | $318K | 13.0% |
| Total | $18.19 avg | 134,276 | $2.4M | 100% |